Introduction:Basic information about CAS 228266-40-8|Taltobulin, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Taltobulin |
|---|
| CAS Number | 228266-40-8 | Molecular Weight | 473.64800 |
|---|
| Density | 1.063g/cm3 | Boiling Point | 662.4ºC at 760 mmHg |
|---|
| Molecular Formula | C27H43N3O4 | Melting Point | 135-137ºC |
|---|
| MSDS | / | Flash Point | 354.4ºC |
|---|
Names
| Name | (E,4S)-4-[[(2S)-3,3-dimethyl-2-[[(2S)-3-methyl-2-(methylamino)-3-phenylbutanoyl]amino]butanoyl]-methylamino]-2,5-dimethylhex-2-enoic acid |
|---|
| Synonym | More Synonyms |
|---|
Taltobulin BiologicalActivity
| Description | Taltobulin (HTI-286; SPA-110) is an analogue of Hemiasterlin; potent tubulin inhibitor; ADCs cytotoxin.IC50 value:Target: tubulinin vitro: HTI-286 significantly inhibited proliferation of all three hepatic tumor cell lines (mean IC50 = 2 nmol/L +/- 1 nmol/L) in vitro. Interestingly, no decrease in viable primary human hepatocytes (PHH) was detected under HTI-286 exposure [1]. In all cell lines tested, HTI-286 was a potent inhibitor of proliferation and induced marked increases in apoptosis. Despite similar transcriptomic changes regarding cell death and cell cycle regulating genes after exposure to HTI-286 or docetaxel, array analysis revealed distinct molecular signatures for both compounds [2].in vivo: Intravenous administration of HTI-286 significantly inhibited tumor growth in vivo (rat allograft model) [1]. HTI-286 significantly inhibited growth of PC-3 and LNCaP xenografts and retained potency in PC-3dR tumors. Simultaneous castration plus HTI-286 therapy was superior to sequential treatment in the LNCaP model [2]. |
|---|
| Related Catalog | Signaling Pathways >>Antibody-drug Conjugate >>ADC CytotoxinSignaling Pathways >>Cell Cycle/DNA Damage >>Microtubule/TubulinSignaling Pathways >>Cytoskeleton >>Microtubule/TubulinResearch Areas >>Cancer |
|---|
| References | [1]. Vashist YK, et al. Inhibition of hepatic tumor cell proliferation in vitro and tumor growth in vivo by taltobulin, a synthetic analogue of the tripeptide hemiasterlin. World J Gastroenterol. 2006 Nov 14;12(42):6771-8. [2]. Hadaschik BA, et al. Targeting prostate cancer with HTI-286, a synthetic analog of the marine sponge product hemiasterlin. Int J Cancer. 2008 May 15;122(10):2368-76. |
|---|
Chemical & Physical Properties
| Density | 1.063g/cm3 |
|---|
| Boiling Point | 662.4ºC at 760 mmHg |
|---|
| Melting Point | 135-137ºC |
|---|
| Molecular Formula | C27H43N3O4 |
|---|
| Molecular Weight | 473.64800 |
|---|
| Flash Point | 354.4ºC |
|---|
| Exact Mass | 473.32500 |
|---|
| PSA | 98.74000 |
|---|
| LogP | 4.37880 |
|---|
| InChIKey | CNTMOLDWXSVYKD-PSRNMDMQSA-N |
|---|
| SMILES | CNC(C(=O)NC(C(=O)N(C)C(C=C(C)C(=O)O)C(C)C)C(C)(C)C)C(C)(C)c1ccccc1 |
|---|
| Storage condition | 2-8℃ |
|---|
Synonyms
| Taltobulin (USAN/INN) |
| SPA-110 |
| HTI-286 |
| Taltobulin |